Ranbaxy Launches Two Generics In Japan

Nihon Pharmaceutical Industry, a joint venture between Ranbaxy and Nippon Chemipar, has launched the new products. Ranbaxy has also pledged to establish a wholly-owned subsidiary in

To read the full article, please choose one of the following options: